In this episode, we unpack the urgent challenges families face when navigating high-risk pediatric cancer, specifically neuroblastoma, and how emerging science in microbiome-based immunotherapy could change the game.We explore:What neuroblastoma is and why it’s so deadly for kidsThe multi-layered costs of accessing treatment, even experimental ones, still in trialHow James Bitzer, a 5-year-old facing his second relapse, represents a wider system failure in pediatric cancer careThe potential of the gut microbiome to reshape immunotherapy outcomes, and the groundbreaking work of Dr. Sabine HazanWhy “hope” in healthcare often comes with a hefty, out-of-pocket price tagFrom trial design to fecal transplants to GoFundMe pages, this episode dives into the intersection of innovation, inequity, and what needs to shift so science can actually save lives.

Ver todos los episodios